The FDA has issued a favorable response to a qualified health claim
petition filed by Nutrition 21 for the nutritional supplement
chromium picolinate, though it concluded that any link between
chromium picolinate and either insulin...
A new animal study found that Nutrition 21's Chromax did not cause
genetic damage in hamster ovary cells, providing further evidence
for the safety of the company's chromium picolinate dietary
supplement and enabling its...
The FDA has requested an extension in its review of yet another
health claims petition, for Nutrition 21's submission linking
chromium picolinate with a reduced risk of insulin resistance, type
2 diabetes and related disease,...
US firm Nutrition 21 will seek to boost sales of chromium
piocolinate in Europe, following acceptance of a scientific dossier
in the UK that gives the ingredient up to four years of derogation
from the food supplements directive,...
The first clinical trial into the effects of chromium
supplementation in children with type 1 diabetes is now underway at
the Childrens' Hospital in Los Angeles, announced Nutrition 21,
which is supplying Chromax chromium picolinate...
The maker of chromium-based supplements has reported a 12.6 percent
sales increase for the quarter ended 31 December 2004, up to $2.6
million compared with $2.3 million for the same period of last
Nutrition 21 said recently that the NIH would continue to fund
research into the benefits of chromium picolinate for sufferes of
diabetes. The company's CEO told NutraIngredientsUSA.com what this
means and her company's...
Nutrition 21 announced last week that a bill signed into law by
President George Bush recognizes the health benefits of chromium
picolinate towards diabetes and urges further research into its